Orogen Royalties Stock EBITDA
OGN Stock | CAD 1.54 0.04 2.67% |
Orogen Royalties fundamentals help investors to digest information that contributes to Orogen Royalties' financial success or failures. It also enables traders to predict the movement of Orogen Stock. The fundamental analysis module provides a way to measure Orogen Royalties' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orogen Royalties stock.
Last Reported | Projected for Next Year | ||
EBITDA | 398 K | 417.9 K |
Orogen | EBITDA |
Orogen Royalties Company EBITDA Analysis
Orogen Royalties' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Orogen Royalties EBITDA | 2.42 M |
Most of Orogen Royalties' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orogen Royalties is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Orogen EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Orogen Royalties is extremely important. It helps to project a fair market value of Orogen Stock properly, considering its historical fundamentals such as EBITDA. Since Orogen Royalties' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Orogen Royalties' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Orogen Royalties' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
Orogen Ebitda
Ebitda |
|
According to the company disclosure, Orogen Royalties reported earnings before interest,tax, depreciation and amortization of 2.42 M. This is 99.7% lower than that of the Metals & Mining sector and 99.38% lower than that of the Materials industry. The ebitda for all Canada stocks is 99.94% higher than that of the company.
Orogen EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orogen Royalties' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orogen Royalties could also be used in its relative valuation, which is a method of valuing Orogen Royalties by comparing valuation metrics of similar companies.Orogen Royalties is currently under evaluation in ebitda category among its peers.
Orogen Royalties Current Valuation Drivers
We derive many important indicators used in calculating different scores of Orogen Royalties from analyzing Orogen Royalties' financial statements. These drivers represent accounts that assess Orogen Royalties' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Orogen Royalties' important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 41.3M | 83.4M | 94.8M | 121.4M | 109.3M | 114.8M | |
Enterprise Value | 38.0M | 81.1M | 91.4M | 115.2M | 103.7M | 108.9M |
Orogen Fundamentals
Return On Equity | 0.0263 | ||||
Return On Asset | 0.0241 | ||||
Profit Margin | 0.22 % | ||||
Operating Margin | 0.58 % | ||||
Current Valuation | 281.25 M | ||||
Shares Outstanding | 201.65 M | ||||
Shares Owned By Insiders | 20.70 % | ||||
Shares Owned By Institutions | 15.91 % | ||||
Number Of Shares Shorted | 17.2 K | ||||
Price To Book | 4.63 X | ||||
Price To Sales | 41.25 X | ||||
Revenue | 7.83 M | ||||
Gross Profit | 7.33 M | ||||
EBITDA | 2.42 M | ||||
Net Income | 3.04 M | ||||
Cash And Equivalents | 11.18 M | ||||
Cash Per Share | 0.06 X | ||||
Total Debt | 1.01 M | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 20.64 X | ||||
Book Value Per Share | 0.32 X | ||||
Cash Flow From Operations | 1.36 M | ||||
Short Ratio | 0.58 X | ||||
Target Price | 2.0 | ||||
Beta | 0.99 | ||||
Market Capitalization | 302.47 M | ||||
Total Asset | 62.59 M | ||||
Retained Earnings | (21.32 M) | ||||
Working Capital | 18.52 M | ||||
Net Asset | 62.59 M |
About Orogen Royalties Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orogen Royalties's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orogen Royalties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orogen Royalties based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orogen Stock Analysis
When running Orogen Royalties' price analysis, check to measure Orogen Royalties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orogen Royalties is operating at the current time. Most of Orogen Royalties' value examination focuses on studying past and present price action to predict the probability of Orogen Royalties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orogen Royalties' price. Additionally, you may evaluate how the addition of Orogen Royalties to your portfolios can decrease your overall portfolio volatility.